134 related articles for article (PubMed ID: 37759156)
21. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity of WT1 gene in the prognosis of sporadic Wilms' tumour in children.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Anticancer Res; 1999; 19(2B):1451-4. PubMed ID: 10365122
[TBL] [Abstract][Full Text] [Related]
23. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
[TBL] [Abstract][Full Text] [Related]
24. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
25. Wilms' Tumour gene 1 (WT1) as an immunotherapeutic target.
Coosemans A
Facts Views Vis Obgyn; 2011; 3(2):89-99. PubMed ID: 24753854
[TBL] [Abstract][Full Text] [Related]
26. Structural rearrangements of the WT1 gene in Wilms' tumour cells.
Cowell JK; Wadey RB; Haber DA; Call KM; Housman DE; Pritchard J
Oncogene; 1991 Apr; 6(4):595-9. PubMed ID: 1851548
[TBL] [Abstract][Full Text] [Related]
27. Multiple roles for the Wilms' tumour suppressor gene, WT1 in genitourinary development.
Schedl A; Hastie N
Mol Cell Endocrinol; 1998 May; 140(1-2):65-9. PubMed ID: 9722170
[TBL] [Abstract][Full Text] [Related]
28. HtrA2, taming the oncogenic activities of WT1.
Hartkamp J; Roberts SG
Cell Cycle; 2010 Jul; 9(13):2508-14. PubMed ID: 20543571
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
30. The role of the Wilms' tumour-suppressor protein WT1 in apoptosis.
Hartkamp J; Roberts SG
Biochem Soc Trans; 2008 Aug; 36(Pt 4):629-31. PubMed ID: 18631130
[TBL] [Abstract][Full Text] [Related]
31. Correlation of Wilms' Tumor 1 (WT1) with Oxidative Stress Markers and Expression of miR-361-5p; New Aspect of WT1 in Breast Cancer.
Pishbin F; Ziamajidi N; Abbasalipourkabir R; Najafi R; Farhadian M
Indian J Clin Biochem; 2023 Jul; 38(3):338-350. PubMed ID: 37234179
[TBL] [Abstract][Full Text] [Related]
32. Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice.
Berry RL; Ozdemir DD; Aronow B; Lindström NO; Dudnakova T; Thornburn A; Perry P; Baldock R; Armit C; Joshi A; Jeanpierre C; Shan J; Vainio S; Baily J; Brownstein D; Davies J; Hastie ND; Hohenstein P
Dis Model Mech; 2015 Aug; 8(8):903-17. PubMed ID: 26035382
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
Cowell JK; Groves N; Baird P
Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
[TBL] [Abstract][Full Text] [Related]
34. An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling.
Kennedy D; Ramsdale T; Mattick J; Little M
Nat Genet; 1996 Mar; 12(3):329-31. PubMed ID: 8589729
[TBL] [Abstract][Full Text] [Related]
35. Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer.
Wagner KJ; Cooper WN; Grundy RG; Caldwell G; Jones C; Wadey RB; Morton D; Schofield PN; Reik W; Latif F; Maher ER
Oncogene; 2002 Oct; 21(47):7277-82. PubMed ID: 12370819
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors.
Amini Nik S; Hohenstein P; Jadidizadeh A; Van Dam K; Bastidas A; Berry RL; Patek CE; Van der Schueren B; Cassiman JJ; Tejpar S
Int J Cancer; 2005 Mar; 114(2):202-8. PubMed ID: 15540161
[TBL] [Abstract][Full Text] [Related]
37. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
Iben S; Royer-Pokora B
Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers.
Oji Y; Miyoshi S; Maeda H; Hayashi S; Tamaki H; Nakatsuka S; Yao M; Takahashi E; Nakano Y; Hirabayashi H; Shintani Y; Oka Y; Tsuboi A; Hosen N; Asada M; Fujioka T; Murakami M; Kanato K; Motomura M; Kim EH; Kawakami M; Ikegame K; Ogawa H; Aozasa K; Kawase I; Sugiyama H
Int J Cancer; 2002 Jul; 100(3):297-303. PubMed ID: 12115544
[TBL] [Abstract][Full Text] [Related]
39. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
[TBL] [Abstract][Full Text] [Related]
40. Wilms' tumour: reconciling genetics and biology.
Van Heyningen V; Hastie ND
Trends Genet; 1992 Jan; 8(1):16-21. PubMed ID: 1369730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
